Pulse Biosciences
PLSE
29 hedge funds and large institutions have $8.89M invested in Pulse Biosciences in 2017 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 0 closing their positions.
547% more capital invested
Capital invested by funds: $1.37M → $8.89M (+$7.52M)
164% more funds holding
Funds holding: 11 → 29 (+18)
1.48% more ownership
Funds ownership: 1.6% → 3.08% (+1.5%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.9M |
| 2 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
+$412K |
| 3 |
BlackRock
New York
|
+$210K |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$191K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$189K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$271K |
| 2 |
JAM
JW Asset Management
Miami Beach,
Florida
|
-$211K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$137K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $6K | +$4.08K | +300 | New |
|
27
Wells Fargo
San Francisco,
California
| $5K | +$3.4K | +250 | New |
|
|
LTFS
28
Ladenburg Thalmann Financial Services
Miami,
Florida
| $4K | +$2.95K | +217 | New |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | – | – | – |
|
PLSE Hedge Fund Activity: Q1 2017 in Review
29 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q1 2017, worth a combined $8.89M — up 547% from $1.37M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new PLSE positions and 0 closed out — a net gain of 21 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.9M. The largest seller was Goldman Sachs, cutting an estimated $271K.
- 29 institutional investors held Pulse Biosciences (PLSE) as of Q1 2017, up from 11 in Q4 2016.
- Funds reported $8.89M of Pulse Biosciences stock for Q1 2017, up 547% quarter-over-quarter.
- 21 funds opened new Pulse Biosciences positions in Q1 2017 and 0 closed out, a net change of +21 holders.
- The largest Pulse Biosciences buyer in Q1 2017 was Vanguard Group, an estimated $1.9M added.
- The largest Pulse Biosciences seller in Q1 2017 was Goldman Sachs, an estimated $271K sold.
Based on aggregated 13F filings for Q1 2017.